RE: RE: Waiting on results...I am quoting ....... "
" ............ A Phase I clinical study for NRM8499 was initiated by BELLUS Health during the first quarter of 2010. The randomized, double-blind, placebo-controlled study will investigate the safety, tolerability and pharmacokinetic profile of NRM8499 in a group of up to 84 young and elderly healthy subjects. The Phase I clinical study is expected to conclude in the second half of 2010. ............. "
"........After over 15 years of significant scientific research, including clinical testing with over 2,000 individuals in 50 U.S. and 17 Canadian medical centres, and hundreds of millions of dollars invested, VIVIMIND™ has been scientifically proven to protect memory function, based on the naturally occurring ingredient, homotaurine. VIVIMIND™ is now available for consumers.
VIVIMIND™ is a patented product based on the ingredient homotaurine, a naturally occurring amino acid with unique properties found in certain seaweed. VIVIMIND™ (homotaurine) is proven to have beneficial effects on brain structure, as well as memory ... "